Former CEO of Trius Therapeutics, Dr. Jeffrey Stein, published a new blog post on The Chairman’s Blog. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
Dr. Jeffrey Stein writes about the government shutdown and its likely impact on companies filing for drug approvals. Read the full blog post from Dr. Jeffrey Stein on TheChairmansBlog.com (http://www.thechairmansblog.com/jeff-stein/2013-10/fda-drug-approvals-congress-giveth-then-taketh-away.html).
TheChairmansBlog.com is an exclusive, online media publication where publically and privatively held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. In addition to management`s insightful blog posts, TheChairmansBlog.com staff and aggregate partners contribute articles on finance, technology, health, and energy while providing updated market trends, news, and information.